A MODULATABLE SWITCH FOR SELECTION OF DONOR MODIFIED CELLS
The disclosed methods are generally directed to preventing, treating, suppressing, controlling or otherwise mitigating side effects of T-cell therapy, the T-cell therapy designed to accelerate immune reconstitution, induce a GVM effect, and/or target tumor cells.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
28.12.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!